[1]
A. Ferraris et al., “Off-label use of rituximab and associated factors in adult patients: a pilot study”, Rev Hosp Ital B.Aires, vol. 37, no. 4, pp. 129–135, Dec. 2017, doi: 10.51987/Rev.Hosp.Ital.B.Aires.v37i4.599.